Welcome to our dedicated page for INTELGENX TECHS news (Ticker: $IGXT), a resource for investors and traders seeking the latest updates and insights on INTELGENX TECHS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect INTELGENX TECHS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of INTELGENX TECHS's position in the market.
IntelGenx Technologies Corp. announced the voting results on the election of directors at their annual meeting, where shareholders voted in favor of all items of business. The meeting was held virtually, with the majority of votes cast in favor of the directors. Detailed results showed the election of eight directors and ratification of the independent auditors for the fiscal year 2024. Shareholders holding 62.79% of the common stock were present at the meeting.
